Biosimilars will be a critical element of the future of healthcare in the United States. Already in Europe, biosimilars have been widely adopted, allowing the European Union to save substantial amounts of money on healthcare.

In this special centennial episode, Richard Williams, R.Ph., Senior Vice President of Pharmaceutical Innovation and Insights at CSI Specialty Group, joins host Andrew Maddigan, Vice President, Client Engagement, to share new insights on the topic of pharmaceutical biosimilars.